Appointment of Joint Corporate Broker
Creo Medical Group plc has appointed Shore Capital Stockbrokers Limited as its Joint Corporate Broker, working alongside existing broker Deutsche Numis. This strategic move aims to enhance the company's financial advisory and brokerage services as it continues to focus on its minimally invasive surgical endoscopy devices for pre-cancer and cancer patients.
Select text to share a quote on X · sign in to keep highlights & notes in your CREO notes
Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces the appointment of Shore Capital Stockbrokers Limited ("Shore Capital") as its Joint Corporate Broker alongside the Company's Nominated Adviser and existing Corporate Broker, Deutsche Numis.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.